Seikagaku: Notice regarding top-line results of the phase III clinical trial (additional trial) of the lumbar disc herniation remedy SI-6603 in the United States

JPX · May 26, 2023 09:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.